secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arbutus Biopharma Corp (ABUS)
CIK:        0001447028
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001447028-25-000104
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arbutus shareholders elect all five director nominees, approve say-on-pay and auditor at 2025 AGM
--------------------------------------------------------------------------------

- All five director nominees elected: Androski, Beardsley, Bishop, Gline, Hasija (avg 123M votes for).
- Non-binding advisory vote on named executive officer compensation passed (122.8M for, 7.0M against).
- Appointment of Ernst & Young as independent auditor for FY2025 ratified (157.7M for).
- Broker non-votes (28.2M) were present on director and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447028/000144702825000104/0001447028-25-000104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447028/000144702825000104/abus-20250521.htm
  HTML page:      https://secwatch.observer/filing/0001447028-25-000104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer